Cargando…
射频消融在EGFR-TKIs治疗非小细胞肺癌后局部进展的初步临床应用
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is one of the foundamental treatment for non-small cell lung cancer (NSCLC) with EGFR mutation, however some patients might develop locally progression in primary site. The aim of this study is to asses...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973449/ https://www.ncbi.nlm.nih.gov/pubmed/27978872 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.12.09 |